The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...
The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
Bellevue Life Sciences Acquisition Corp. ("BLAC") announced today the approval of each of the proposals presented at the ...
AliveDx seeks US FDA 510(k) premarket approval for MosaiQ AiPlex CD multiplex microarray: Eysins, Switzerland Tuesday, February 11, 2025, 12:00 Hrs [IST] AliveDx, an established c ...
Medpage Today on MSN1d
Most Clozapine Prescribers Satisfied With REMS ProgramAmong 196 doctors who prescribed clozapine, 64% said the positive aspects of the REMS certification process outweighed the ...
Hims & Hers hit the bullseye with its Super Bowl ad, sparking a surge in clicks to its site.The ad also hit a nerve with the ...
GlobalData on MSN1d
QuantalX’s brain health assessment device gains CE MDR approvalQuantalX Neuroscience has gained the European CE Medical Device Regulation (MDR) approval for the Delphi-MD, a device for ...
Telehealth company Hims & Hers stirred up controversy by debuting a 2025 Super Bowl ad touting the benefits of its ...
News Nation on MSN2d
Hims & Hers Super Bowl ad sparks weight-loss drug backlashTelehealth company Hims & Hers is being called out over its Super Bowl ad going after Big Pharma and popular weight-loss ...
Palindrome Technologies has been recognized as an official testing facility for the IEEE Medical Device Cybersecurity ...
Fin vs Fin on MSN9h
Zealthy vs Ro: Which Weight Loss Plan Works Best?Zealthy and Ro both offer FDA-approved, generic GLP-1s at personalized dosages to fit your needs. These platforms also have a ...
In the absence of strong state and federal regulations, some suburbs have banned the sale of hemp products that get users ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback